Wespac Advisors, LLC Bristol Myers Squibb CO Transaction History

Wespac Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 27, 2020	SELL	$57.43 - $63.64 $1.52 Million - $1.68 Million	-26,391 Closed	0 $0
Q2 2020 Jul 22, 2020	SELL	$54.82 - $64.09 $81,407 - $95,173	-1,485 Reduced 5.33%	26,391 $1.55 Million
Q1 2020 Apr 22, 2020	SELL	$46.4 - $67.43 $117,624 - $170,935	-2,535 Reduced 8.34%	27,876 $1.55 Million
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $1.5 Million - $1.95 Million	30,411 New	30,411 $1.95 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Wespac Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Wespac Advisors, LLC with notifications on news.